Elite Pharmaceuticals Inc (ELTP)

[no2koolaid]

Let's make it real simple to reduce the need to read such a long post...here is what tells you Elite is doing fine over the longer 3 year term...

Now let’s compare 2017 to 2014 for a better growth picture. As noted, 2017 saw revenues per share of .0114, while in 2014 there was a .0087 ratio of revenues per share. So the math problem is .0114 (where Elite is) minus .0087 (where Elite was) = .0027 divided by .0087 = .31034 or a 31.034% INCREASE in revenues per share over a three-year period.

As the numbers clearly show, Elite is a better company today than it was three years ago. The numbers, no matter how sliced, speak the truth and, when we add in the partnerships and the ADF portfolio potential, the business assessment is obvious…Elite is a business in position for even longer-term growth and success. What is it I say at this point? PERIOD